𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Positive phase II study in the treatment of advanced malignant melanoma with fotemustine

✍ Scribed by Karin U. Schallreuter; Eberhard Wenzel; Frank W. Brassow; Jürgen Berger; Eckard W. Breitbart; Wolfgang Teichmann

Publisher
Springer
Year
1991
Tongue
English
Weight
331 KB
Volume
29
Category
Article
ISSN
0344-5704

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Treatment of metastatic malignant melano
Treatment of metastatic malignant melanoma with trimetrexate: A phase II study
✍ Odujinrin, Oluwole ;Goldberg, David ;Doroshow, James ;Leong, Lucille ;Margolin, 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 361 KB

## Abstract Trimetrexate glucuronate, a nonclassical antifolate, was administered to 14 patients with recurrent and progressive metastatic malignant melanoma. Thirteen patients were evaluable for response and toxicity. Five patients had received prior treatment consisting of immunotherapy (one pati

Interferon in combination with vinblasti
Interferon in combination with vinblastine in advanced malignant melanoma. A phase I–II study
✍ Stein Gundersen; A. Flokkmann 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 288 KB 👁 2 views

Nineteen patients with advanced malignant melanoma were treated with a combination of recombinant alfa-interferon (a-IFN) and vinblastine (VBL). The a-IFN was administered subcutaneously daily at an initial dose of 3 X lo6 IU escalating to a maximal dose of 9 X lo6 U daily for the first 10 weeks fol